Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Trading Arrangement: Trading Arrangement [Axis] Maximum Maximum [Member] Title of 12(b) Security Title of 12(b) Security Net loss attributable to common stockholders, diluted Net loss attributable to common stockholders, diluted Net Income (Loss) Available to Common Stockholders, Diluted Quarterly amortization rate Debt Instrument, Quarterly Amortization Rate Debt Instrument, Quarterly Amortization Rate Adjustment to Compensation, Amount Adjustment to Compensation Amount Financial Instrument [Axis] Financial Instrument [Axis] Segment Reporting [Abstract] Compensation, including bonuses, fringe benefits, and payroll taxes Employee-related Liabilities, Current Leases Lessee, Finance Leases [Text Block] Shares issued per unit held (in shares) Sale Of Stock, Shares Issued Per Unit Sale Of Stock, Shares Issued Per Unit Contract with customer, asset Contract with Customer, Asset, after Allowance for Credit Loss 2027 Finance Lease, Liability, to be Paid, Year One Accrued insurance reserve Accrued Insurance, Current Derivative Instrument [Axis] Derivative Instrument [Axis] Number of securities called by warrants or rights (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Debt instrument, convertible, conversion price (in dollars per share) Debt Instrument, Convertible, Conversion Price Proceeds from asset disposition Proceeds from Sale of Productive Assets Consolidated Entities [Axis] Consolidated Entities [Axis] Number of equity offerings Number Of Equity Offerings Number Of Equity Offerings Other liabilities Other Sundry Liabilities, Current Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Conversion cap (in shares) Debt Instrument, Convertible, Conversion Cap, Shares Debt Instrument, Convertible, Conversion Cap, Shares Leases [Abstract] Amortization period of debt discount (in years) Debt Instrument, Convertible, Discount Amortization Period Debt Instrument, Convertible, Discount Amortization Period Consolidated Entities [Domain] Consolidated Entities [Domain] Embedded conversion option feature Embedded Conversion Option Feature [Member] Embedded Conversion Option Feature Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Issuance of warrant liability Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuance Of Warrant Liability Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuance Of Warrant Liability Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Axis] Intangible assets, net Intangible Asset, Excluding Goodwill, after Accumulated Amortization Number of shares outstanding (in shares) Balance at the beginning (in shares) Balance at the end (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number First anniversary of grant date Share-Based Payment Arrangement, Tranche One [Member] Accrued insurance Accrued Insurance Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Repayments on advances Repayments On Advances Repayments On Advances Number of reportable segments Number of Reportable Segments Total current liabilities Liabilities, Current Mark Pacala [Member] Mark Pacala Capitated revenue Capitated Revenue [Member] Represents the information about capitated revenue. Concentration Risk [Table] Concentration Risk [Table] Entity Address, City or Town Entity Address, City or Town Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Share-based Compensation Arrangement by Share-based Payment Award Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Receivables [Abstract] Statement of Financial Position [Abstract] Net carrying amount Intangible Asset, Finite-Lived, after Accumulated Amortization Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Level 2 Fair Value, Inputs, Level 2 [Member] Other non-operating expense (income) Nonoperating Income (Expense) [Abstract] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Issuance of common stock upon vesting RSUs (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Gross Concentration Risk Type [Axis] Concentration Risk Type [Axis] Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Warrant redemption maximum common share price (in dollars per share) Class Of Warrant Or Right, Warrant Redemption Condition, Maximum Common Share Price Class Of Warrant Or Right, Warrant Redemption Condition, Maximum Common Share Price Summary of Financial Information for the Company's Segments Segment Reporting [Table Text Block] Use of Estimates Use of Estimates, Policy [Policy Text Block] Related Party [Axis] Related and Nonrelated Parties [Axis] Summary of Changes in Fair Value of Level 3 Warrant Liabilities Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Minimum unrestricted cash and cash equivalent balance Debt Instrument, Covenant, Minimum Cash Threshold Removal Debt Instrument, Covenant, Minimum Cash Threshold Removal Redemption period two Debt Instrument, Redemption, Period Two [Member] Accounts receivable, remaining amount Accounts Receivable, After Allowance for Credit Loss, Remaining Amount Accounts Receivable, After Allowance for Credit Loss, Remaining Amount Summary of Operating Lease Maturity Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Supplemental disclosure of noncash investing and financing activities: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Document Period End Date Document Period End Date FFS accounts receivable, net (Patient Services) Ffs Accounts Receivable [Member] Represents the information pertaining to FFS accounts receivable. Series A preferred shares, outstanding (in shares) Balance at beginning (in shares) Balance at ending (in shares) Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Debt instrument, face amount Debt Instrument, Face Amount 2028 Lessee, Operating Lease, Liability, to be Paid, Year Two Private Warrants Private Warrants [Member] Private Warrants Treasury Stock at cost, 1,733,774 shares at September 30, 2026 and December 31, 2025 Treasury Stock, Common, Value Interest rate Debt Instrument, Interest Rate, Effective Percentage RSUs and RSAs Restricted Stock Units And Awards [Member] Restricted Stock Units And Awards Line of credit facility, maximum loan turn days Line Of Credit Facility, Maximum Loan Turn Days Line Of Credit Facility, Maximum Loan Turn Days Medical RSUs Medical Restricted Stock Units RSUs [Member] Medical Restricted Stock Units RSUs Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Finance Finance Lease, Weighted Average Remaining Lease Term Component one Variable Rate Component One [Member] Variable Rate Component One Entity Shell Company Entity Shell Company Consolidation Items [Domain] Consolidation Items [Domain] Change in fair value included in other expense Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Current portion of operating lease liabilities Lease liabilities, current Operating Lease, Liability, Current Accrued capitated leakage Accrued Capitated Leakage Accrued Capitated Leakage Net Loss Per Share Earnings Per Share [Text Block] Net loss per share attributable to common stockholders: Earnings Per Share [Abstract] Document Fiscal Period Focus Document Fiscal Period Focus Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Total liabilities Total liabilities Liabilities Trading Symbol Trading Symbol Fair Value Debt Securities, Available-for-Sale, Excluding Accrued Interest Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Company Selected Measure Name Company Selected Measure Name Sale of Stock [Domain] Sale of Stock [Domain] Income Tax Disclosure [Abstract] Write-off of assets from clinical trials segment Loss on sale due to the write-off Loss On Segment Assets Written-Off Loss On Segment Assets Written-Off Significant Risks and Uncertainties Including Business and Credit Concentrations Concentration Risk [Line Items] Credit Facility [Domain] Credit Facility [Domain] Depreciation and amortization Non-segment depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Patient services Health Care, Patient Service [Member] Cash flows from operating activities: Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Other receivables Other Receivables, Net, Current Cash paid for amounts included in the measurement of lease liabilities: Cash paid for amounts included in the measurement of lease liabilities [Abstract] Cash paid for amounts included in the measurement of lease liabilities [Abstract] Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Useful lives Property, Plant, and Equipment, Useful Life 2028 Finance Lease, Liability, to be Paid, Year Two Threshold consecutive trading days (in days) Class Of Warrant Or Right, Redemption Of Warrants Or Rights, Threshold Consecutive Trading Days Class Of Warrant Or Right, Redemption Of Warrants Or Rights, Threshold Consecutive Trading Days 2030 Finance Lease, Liability, to be Paid, Year Four Percentage of stock options Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Less: amount representing interest Finance Lease, Liability, Undiscounted Excess Amount Cash and Cash Equivalents Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Operating cash payment for operating leases Operating Lease, Payments Award Timing Predetermined Award Timing Predetermined [Flag] Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Share-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Level 1 Fair Value, Inputs, Level 1 [Member] Summary of Concentration Risk Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Exercise Price Measurement Input, Exercise Price [Member] Effective income tax rate reconciliation, percent Effective Income Tax Rate Reconciliation, Percent Line of credit facility, collateral monitoring fee percentage Line of Credit Facility, Collateral Monitoring Fee Percentage Line of Credit Facility, Collateral Monitoring Fee Percentage Inventory, Current [Table] Inventory, Current [Table] Number of states in which entity operates Number of States in which Entity Operates Change in operating leases Increase (Decrease) in Operating Lease Liability Series A preferred shares, par value (in dollars per share) Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Depreciation expense Total segment depreciation expense Depreciation Plan Name [Domain] Plan Name [Domain] Vesting [Domain] Vesting [Domain] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Total Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost Balance at the beginning (in dollars per share) Balance at the end (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Operating right of use assets Operating Lease, Right-of-Use Asset Concentration Risk Type [Domain] Concentration Risk Type [Domain] Karen Johnson [Member] Karen Johnson Due in One Year or Less Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One Thereafter Long-Term Debt, Maturity, After Year Four Long-Term Debt, Maturity, After Year Four Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Make-whole amount Debt Extinguishment, Make Whole Amount Debt Extinguishment, Make Whole Amount Outstanding borrowings Long-Term Line of Credit Thereafter Finite-Lived Intangible Asset, Expected Amortization, after Year Four Finite-Lived Intangible Asset, Expected Amortization, after Year Four Expiration Date Trading Arrangement Expiration Date Net increase (decrease) in cash and cash equivalents Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation 2030 Long-Term Debt, Maturity, Year Four Direct costs Cost of Goods and Service Benchmark [Member] Cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Specialty pharmacy Specialty Pharmacy, Segment [Member] Specialty Pharmacy, Segment Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost [Abstract] Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost [Abstract] Vested options exercisable at the end (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Thereafter Finance Lease, Liability, to be Paid, After Year Four Finance Lease, Liability, to be Paid, After Year Four Proceeds from at-the-market offering, net of offering costs Gross proceeds from sale of common stock Proceeds from Issuance of Common Stock Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Security, Excluded EPS Calculation [Table] Cash flows from investing activities: Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Segments [Domain] Segments [Domain] Debt Debt Disclosure [Text Block] Deferred acquisition and contingent consideration Business Combination, Consideration Transferred, Other, Current Business Combination, Consideration Transferred, Other, Current Specialty pharmacy Specialty Pharmacy [Member] Specialty Pharmacy Debt issuance costs Less: Unamortized debt issuance costs Debt Issuance Costs, Net Supplier Concentration Supplier Concentration Risk [Member] Consideration transferred Debt Extinguishment, Consideration Transferred, Amount Debt Extinguishment, Consideration Transferred, Amount PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Term loan agreement Secured Debt [Member] Certain convertible debt lenders Certain Convertible Debt Lenders [Member] Certain Convertible Debt Lenders Finance Finance Lease, Weighted Average Discount Rate, Percent Interest rate (as a percent) Debt Instrument, Interest Rate, Stated Percentage Total stockholders’ deficit Balance at beginning Balance at ending Equity, Attributable to Parent Assets Assets [Abstract] Insider Trading Policies and Procedures [Line Items] Allowance for credit losses Accounts Receivable, Allowance for Credit Loss, Current Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Deferred taxes Deferred Income Tax Expense (Benefit) Private placement Private Placement [Member] Finance lease ROU assets Finance Lease ROU Assets [Member] Finance Lease ROU Assets [Member] Dividend yield Measurement Input, Expected Dividend Rate [Member] Antidilutive securities excluded from computation of earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Number of operating segments Number of Operating Segments Summary of Goodwill and Changes in the Carrying Amount of Goodwill Goodwill [Table Text Block] Entity Central Index Key Entity Central Index Key Less: accumulated depreciation Property, Plant, and Equipment, Accumulated Depreciation, Depletion, and Amortization Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Extinguishment of optional redemption derivative liability Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Liability, Extinguishment Of Optional Redemption Derivative Liability Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Liability, Extinguishment Of Optional Redemption Derivative Liability Debt securities, available-for-sale, accrued interest, after allowance for credit loss, current, statement of financial position [Extensible Enumeration] Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss, Current, Statement of Financial Position [Extensible Enumeration] 2026 (remaining three months) Long-Term Debt, Maturity, Remainder of Fiscal Year Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Medical supplies and other Medical Supplies And Other, Segment [Member] Medical Supplies And Other, Segment Lease liabilities, noncurrent Finance Lease, Liability, Noncurrent Proceeds from at the market offering in other current assets Proceeds From At The Market Offering In Other Current Assets Proceeds From At The Market Offering In Other Current Assets Total fair value of common shares vested Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value Number of shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Redemption period one Debt Instrument, Redemption, Period One [Member] Total future lease payment Finance Lease, Liability, to be Paid All Individuals All Individuals [Member] Unrecognized compensation cost expected to be recognized over a weighted average period (in years) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Statement [Line Items] Statement [Line Items] Total assets Total assets Total assets Assets Operating Leases Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] Accounts Receivable and Allowance for Credit Losses Accounts Receivable [Policy Text Block] Capital shares reserved for future issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance Employee Stock Purchase Plan Employee Stock Purchase Plan [Member] Employee Stock Purchase Plan Convertible notes Convertible Debt [Member] Operating segments Operating Segments [Member] Interest expense, net Interest expense, net Interest Expense, Nonoperating Gross Unrealized Gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Share-Based Compensation Share-Based Payment Arrangement [Text Block] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] PEO PEO [Member] 2028 Long-Term Debt, Maturity, Year Two Rent expense increase Lessee, Operating Lease, Modification, Increase (Decrease) In Rent Expenses Lessee, Operating Lease, Modification, Increase (Decrease) In Rent Expenses Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense Other non-current liabilities Other non-current liabilities Other Liabilities, Noncurrent Goodwill Goodwill Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Component two Variable Rate Component Two [Member] Variable Rate Component Two Accumulated Deficit Retained Earnings [Member] Operating lease liabilities Lease liabilities, noncurrent Operating Lease, Liability, Noncurrent Revolving credit facility Revolving Credit Facility [Member] Money Market Fund Money Market Funds [Member] Fair Value Measurements Fair Value Measurement, Policy [Policy Text Block] Changes in Stockholders' Equity Increase (Decrease) in Stockholders' Equity [Roll Forward] Common stock, shares outstanding (in shares) Balance at beginning (in shares) Balance at ending (in shares) Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Award Timing Disclosures [Line Items] Summary of Carrying Amounts of Financial Instruments Fair Value, by Balance Sheet Grouping [Table Text Block] Diluted (in dollars per share) Net loss income per share attributable to common stockholders, diluted (in dollars per share) Earnings Per Share, Diluted Fair value of bifurcated optional redemption feature Debt Instrument, Fair Value Of Bifurcated Optional Redemption Feature Debt Instrument, Fair Value Of Bifurcated Optional Redemption Feature Amortization expense Total segment amortization Intangible Asset, Finite-Lived, Amortization Expense Stockholders' Equity Note [Abstract] Intangible Asset, Finite-Lived [Line Items] Intangible Asset, Finite-Lived [Line Items] Share-Based Payment Arrangement [Abstract] Total operating revenue Consolidated revenue Revenue from Contract with Customer, Excluding Assessed Tax Line of credit facility, available borrowing capacity Line of Credit Facility, Remaining Borrowing Capacity Financial assets: Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Exchange agreement Exchange Agreement, Units Without Warrants [Member] Exchange Agreement, Units Without Warrants Construction in progress Construction in Progress [Member] Amortization period of debt issuance cost (in years) Debt Instrument, Debt Issuance Cost, Amortization Period Debt Instrument, Debt Issuance Cost, Amortization Period Summary of Maturities of Long-Term Debt Schedule of Maturities of Long-Term Debt [Table Text Block] Sale of Stock [Axis] Sale of Stock [Axis] Weighted average remaining contractual term (years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Accrued Expenses and Other Current Liabilities Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] At The Market Offering At The Market Offering [Member] At The Market Offering Public Warrants Public Warrants [Member] Represents information pertaining to public warrants. Loss from operations Operating Income (Loss) Thereafter Lessee, Operating Lease, Liability, to be Paid, After Year Four Lessee, Operating Lease, Liability, to be Paid, After Year Four Summary of Finance Lease Maturity Finance Lease, Liability, to be Paid, Maturity [Table Text Block] 2026 (remaining three months) Finance Lease, Liability, to be Paid, Remainder of Fiscal Year Proceeds from issuance of debt Proceeds from Issuance of Debt Clinical trials & other Clinical research trials and other revenue Clinical Research Trials And Other Revenue [Member] Represents the information pertaining to Clinical trials & other. Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Arizona ARIZONA Warrants in connection with Convertible Notes Warrants In Connection With Convertible Notes [Member] Warrants In Connection With Convertible Notes Oral drug inventory Oral Drug Inventory [Member] Represents the information about Oral drug inventory. Basic and diluted net income (loss) per share of common stock: Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Common stock, shares issued (in shares) Common Stock, Shares, Issued Description of the Business Business Description and Basis of Presentation [Text Block] Clinical contracts and noncompete agreements Clinical Contracts And Noncompete Agreements [Member] Represents information pertaining to clinical contracts. Direct costs Total segment direct costs Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization Accounts receivable Increase (Decrease) in Accounts Receivable Product and Service [Domain] Product and Service [Domain] Common and Preferred Shares Class of Stock [Line Items] California CALIFORNIA Clinical trials & other Clinical Trials And Other, Segment [Member] Clinical Trials And Other, Segment Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Number of common stock, vote per share (in votes) Common Stock, Votes Per Share Common Stock, Votes Per Share Variable Interest Entities Variable Interest Entity [Line Items] Supplier Finance Program [Line Items] Supplier Finance Program [Line Items] Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Capitated accounts receivable Capitated Accounts Receivable, Segment [Member] Capitated Accounts Receivable, Segment 2029 Lessee, Operating Lease, Liability, to be Paid, Year Three Termination Date Trading Arrangement Termination Date IV drug inventory Iv Drug Inventory [Member] Represents the information about IV drug inventory. Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Interest accrued Debt Instrument, Increase, Accrued Interest Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Total accrued expenses and other current liabilities Amounts due to affiliates Other Liabilities, Current Term of award (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Accrued expenses and other current liabilities Accrued Liabilities, Current Fair Value as of Grant Date Award Grant Date Fair Value Goodwill [Table] Goodwill [Table] Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Total operating expenses Operating Costs and Expenses Arrangement Duration Trading Arrangement Duration Consolidation Items [Axis] Consolidation Items [Axis] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Registrant Name Entity Registrant Name Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Public and Private Warrants Public and Private Warrants [Member] Public and Private Warrants Gross carrying amount Intangible Asset, Finite-Lived, before Accumulated Amortization Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Amortization of ROU asset Finance Lease, Right-of-Use Asset, Amortization Common warrants Common Warrants [Member] Common Warrants Change in fair value of warrant and conversion option derivative liabilities Change in fair value of warrant and conversion option derivative liabilities Change In Fair Value Of Warrant And Conversion Option Derivative Liabilities Change In Fair Value Of Warrant And Conversion Option Derivative Liabilities Office furniture Furniture and Fixtures [Member] Intangible Asset, Finite-Lived, Class [Domain] Intangible Asset, Finite-Lived, Class [Domain] Vested options exercisable at the end (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted-Average Remaining Contractual Term Trade names Trade Names [Member] Award Type [Domain] Award Type [Domain] Interest expense Finance Lease, Interest Expense 2026 (remaining three months) Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Marketable Securities and Fair Value Measurements Fair Value Disclosures [Text Block] Level 3 Fair Value, Inputs, Level 3 [Member] Aggregate intrinsic value of vested Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Aggregate Intrinsic Value, Vested Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Aggregate Intrinsic Value, Vested 2027 Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year One Operating lease term (in years) Lessee, Operating Lease, Term of Contract Geographical [Axis] Geographical [Axis] Accrued expenses and other current liabilities Increase (Decrease) in Accrued Liabilities Contract liabilities Contract with Customer, Liability Liability Class [Axis] Liability Class [Axis] Minimum threshold written notice period for redemption of public warrants Class of Warrant Or Right, Redemption Period, Written Notice Class of Warrant Or Right, Redemption Period, Written Notice Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Intangible Asset, Finite-Lived [Table] Intangible Asset, Finite-Lived [Table] Accounts receivable, bad debt recovery Accounts Receivable, Allowance for Credit Loss, Recovery (Reversal) Accounts Receivable, Allowance for Credit Loss, Recovery (Reversal) Non-NEOs Non-NEOs [Member] Reporting Unit [Domain] Reporting Unit [Domain] 2028 Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Two Warrant and conversion option derivative liabilities Warrant And Conversion Option Derivative Liabilities, Noncurrent Warrant And Conversion Option Derivative Liabilities, Noncurrent Customer [Domain] Customer [Domain] Summary of Inventories Schedule of Inventory, Current [Table Text Block] Leases Lessee, Operating Leases [Text Block] 2027 Long-Term Debt, Maturity, Year One Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Patient services Patient Services, Segment [Member] Patient Services, Segment Weighted-average discount rate Weighted-Average Discount Rate [Abstract] Weighted-Average Discount Rate Risk-free rate Measurement Input, Risk Free Interest Rate [Member] Statistical Measurement [Axis] Statistical Measurement [Axis] Supplier Finance Program [Table] Supplier Finance Program [Table] Award Type [Axis] Award Type [Axis] Clinician salaries and benefits Clinician Salaries And Benefits, Segment [Member] Clinician Salaries And Benefits, Segment Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, after Allowance for Credit Loss Accumulated deficit Retained Earnings (Accumulated Deficit) Florida FLORIDA Specialty Pharmacy Specialty pharmacy revenue Health Care, Specialty Pharmacy [Member] Health Care, Specialty Pharmacy Product and Service [Axis] Product and Service [Axis] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Common Stock Common Stock Common Stock [Member] Operating lease costs: Operating Lease, Cost Shares issued in period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period Year ending December 31: Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity [Abstract] Derivative Contract [Domain] Derivative Contract [Domain] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Directors and officers insurance premiums Insurance Premiums, Current Insurance Premiums, Current Total liabilities and stockholders’ deficit Liabilities and Equity Variable lease costs Variable Lease, Cost Fair value of warrants issued Class Of Warrant or Right, Issued Class Of Warrant or Right, Issued Line of credit facility, minimum required balance Line Of Credit Facility, Minimum Required Balance Line Of Credit Facility, Minimum Required Balance Stock options Share-Based Payment Arrangement, Option [Member] Optional redemption Optional Redemption [Member] Optional Redemption Segments [Axis] Segments [Axis] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Related Party [Domain] Related and Nonrelated Parties [Domain] Tabular List, Table Tabular List [Table Text Block] Vesting [Axis] Vesting [Axis] Additional paid-in capital Additional Paid in Capital Fair value of the liability-classified medical RSU outstanding Share-based Compensation Arrangement By Share-based Payment Award, Plan Modification, Fair Value Of The Liability-classified Medical RSU Outstanding Share-based Compensation Arrangement By Share-based Payment Award, Plan Modification, Fair Value Of The Liability-classified Medical RSU Outstanding 2029 Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Three 2026 (remaining three months) Intangible Asset, Finite-Lived, Estimated Amortization Expense, Remainder of Fiscal Year Name Awards Close in Time to MNPI Disclosures, Individual Name Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Aggregate intrinsic value (in thousands) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Summary of Accrued Expenses and Other Current Liabilities Other Current Liabilities [Table Text Block] Long-Lived Asset, Class [Domain] Long-Lived Asset, Class [Domain] Sale of stock, price (in dollars per share) Sale of Stock, Price Per Share Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Property, Plant, and Equipment [Table] Property, Plant, and Equipment [Table] Series A Convertible Preferred Stock, $0.0001 par value, authorized 10,000,000 shares; 193,507 shares issued and outstanding at September 30, 2026 and December 31, 2025 Preferred Stock, Value, Issued Adjustment to Compensation: Adjustment to Compensation [Axis] Increase in lease liability and right-of-use asset Lessee, Operating Lease, Increase In Liability And Right-Of-Use Asset Lessee, Operating Lease, Increase In Liability And Right-Of-Use Asset Supplier [Axis] Supplier [Axis] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Interest Interest Paid, Excluding Capitalized Interest, Operating Activity Extinguishment of debt Extinguishment of Debt, Amount Facility Agreement Facility Agreement [Member] Facility Agreement Inventory [Line Items] Inventory [Line Items] Credit Facility [Axis] Credit Facility [Axis] Name Measure Name Pay vs Performance Disclosure [Line Items] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Debt Instrument [Line Items] Debt Instrument [Line Items] Variable Rate Component [Axis] Variable Rate Component [Axis] Variable Rate Component Entity Information, Former Legal or Registered Name Entity Information, Former Legal or Registered Name Additional Paid in Capital Additional Paid-in Capital [Member] Medical equipment Equipment [Member] Goodwill impairment charges Goodwill, Impairment Loss Weighted-average remaining lease term (in years) Weighted-Average Remaining Lease Term [Abstract] Weighted-Average Remaining Lease Term Name Trading Arrangement, Individual Name Unrecognized compensation expense Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Term (in years) Measurement Input, Expected Term [Member] Company Selected Measure Amount Company Selected Measure Amount Depreciation and amortization Depreciation, Depletion and Amortization Net loss attributable to Starling available for distribution Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic Accounts and Financing Receivables [Table] Accounts and Financing Receivables [Table] Operating Operating Lease, Weighted Average Remaining Lease Term Derivative warrant liabilities Derivative Warrant Liabilities, Noncurrent Derivative Warrant Liabilities, Noncurrent Non-PEO NEO Non-PEO NEO [Member] Term from closing of IPO Class of Warrant or Right, Exercisable, Term From Closing Of Initial Public Offering Class of Warrant or Right, Exercisable, Term From Closing Of Initial Public Offering Customer Concentration Customer Concentration Risk [Member] Award Timing Method Award Timing Method [Text Block] Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Warrant and Conversion Option Derivative Liability Warrant And Conversion Option Derivative Liability [Member] Warrant And Conversion Option Derivative Liability Net loss Net loss Net loss Net loss attributable to Starling Net Income (Loss) Attributable to Parent Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Restatement Determination Date: Restatement Determination Date [Axis] Number of securities called by each warrant (in shares) Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Vested options exercisable at the end (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Oral drug inventory Oral Drug Inventory, Segment [Member] Oral Drug Inventory, Segment Capitated accounts receivable (Patient Services) Capitated Accounts Receivable [Member] Represents the information pertaining to capitated accounts receivable. Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Revenue Revenues [Abstract] Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Weighted average amortization period Intangible Asset, Finite-Lived, Remaining Amortization Period Statistical Measurement [Domain] Statistical Measurement [Domain] Issuance of common stock upon exercise of warrants Stock Issued During Period, Value, Issued for Services Document Fiscal Year Focus Document Fiscal Year Focus Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Customer [Axis] Customer [Axis] Common Stock, $0.0001 par value, authorized 500,000,000 shares; 103,724,798 shares issued and 101,991,024 shares outstanding at September 30, 2026 and 100,596,918 shares issued and 98,863,144 shares outstanding at December 31, 2025 Common Stock, Value, Issued 2027 Lessee, Operating Lease, Liability, to be Paid, Year One Summary of Long-Term Debt, Net of Unamortized Debt Issuance Costs Schedule of Long-Term Debt Instruments [Table Text Block] Award requisite service period (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period Recourse Status [Axis] Recourse Status [Axis] Line of credit Line of Credit [Member] Restatement Determination Date Restatement Determination Date Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] FFS accounts receivable FFS Accounts Receivable, Segment [Member] FFS Accounts Receivable, Segment Net loss attributable to participating securities, basic Participating Securities, Distributed and Undistributed Earnings (Loss), Basic Service allowance for doubtful accounts Accounts Receivable, Allowance for Credit Loss Amendment Flag Amendment Flag Goodwill [Line Items] Goodwill [Line Items] Current liabilities: Liabilities, Current [Abstract] Bad debt expense Accounts Receivable, Credit Loss Expense (Reversal) Inventory [Axis] Inventory [Axis] Principal payments on financing leases Finance Lease, Principal Payments Gross Unrealized Losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Goodwill Goodwill and Intangible Assets, Policy [Policy Text Block] Summary of Investment Securities Classified as Available-for-sale Debt Securities, Available-for-Sale [Table Text Block] Operating leases Right-Of-Use Asset Obtained In Exchange For Operating Lease Liability, Net Right-Of-Use Asset Obtained In Exchange For Operating Lease Liability, Net Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Property, Plant, and Equipment [Abstract] Entity Address, State or Province Entity Address, State or Province PEO Total Compensation Amount PEO Total Compensation Amount Change in fair value of liability classified warrants and conversion option derivative Change In Fair Value Of Liability Classified Warrants And Conversion Option Derivative Change In Fair Value Of Liability Classified Warrants And Conversion Option Derivative Basic (in shares) Weighted average common shares outstanding, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Goodwill impairment charges Goodwill, Impaired, Accumulated Impairment Loss Principal exchange of convertible note for preferred stock Convertible Preferred Stock Converted to Other Securities 2030 Lessee, Operating Lease, Liability, to be Paid, Year Four Expired (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Expired in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Expired in Period Sales Agent, BTIG BTIG [Member] BTIG Minimum number of clinic locations within three states Number Of Clinic Locations Number Of Clinic Locations Accounts Receivable Loans, Notes, Trade and Other Receivables Disclosure [Text Block] Payor B Payor B [Member] Represents the information pertaining to Payor B. Document Information [Line Items] Document Information [Line Items] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Class of Stock [Axis] Class of Stock [Axis] Oral drug accounts receivable Oral Drug Accounts Receivable, Segment [Member] Oral Drug Accounts Receivable, Segment Net loss attributable to common stockholders, basic Net loss attributable to common stockholders, basic Net Income (Loss) Available to Common Stockholders, Basic Percentage of Net Revenue Revenue from Contract with Customer Benchmark [Member] Proceeds from employee stock purchase plan Proceeds From Employee Stock Purchase Plan Proceeds From Employee Stock Purchase Plan Accumulated amortization Intangible Asset, Finite-Lived, Accumulated Amortization Receivable [Domain] Receivable [Domain] Line of credit facility, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Recently Issued and Adopted Accounting Standards New Accounting Pronouncements, Policy [Policy Text Block] Net Loss Per Share Earnings Per Share, Policy [Policy Text Block] Loss on disposal of property and equipment Gain (Loss) on Disposition of Property Plant Equipment Other trade receivables Other Trade Receivable [Member] Represents the information pertaining to other trade receivables. Amortization of debt issuance costs and debt discount Amortization of Debt Issuance Costs Long-term debt Long-term debt, net of unamortized debt discount and issuance costs Long-Term Debt Warrants price per share (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Property and Equipment, Net Property, Plant, and Equipment [Text Block] Variable Rate Component [Domain] Variable Rate Component [Domain] Variable Rate Component [Domain] Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Net cash and cash equivalents used in investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Maximum percent of common stock allowed Preferred Stock, Maximum Percent of Common Stock Allowed Preferred Stock, Maximum Percent of Common Stock Allowed Minimum net revenue Debt Instrument, Covenant, Minimum Net Revenue Debt Instrument, Covenant, Minimum Net Revenue Stockholders' Equity (Deficit) Equity [Text Block] Security Exchange Name Security Exchange Name Granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Line of credit facility early termination fee percentage Line Of Credit Facility Early Termination Fee Percentage Line Of Credit Facility Early Termination Fee Percentage Maximum total number of common shares for which stock options may be granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Issuance of common stock upon exercise of warrants (in shares) Stock Issued During Period, Shares, Issued for Services Accrued interest Interest Payable, Current Expired (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Expired in Period, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Expired in Period, Weighted Average Exercise Price Segment Reporting Segment Reporting, Policy [Policy Text Block] Summary of Property and Equipment, Net Property, Plant, and Equipment [Table Text Block] Name Outstanding Recovery, Individual Name Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Variable Interest Entities Consolidation, Variable Interest Entity, Policy [Policy Text Block] Shares issued upon conversion (in shares) Convertible Preferred Stock, Shares Issued upon Conversion Geographical [Domain] Geographical [Domain] Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Unrecognized compensation cost Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Payments made for financing of insurance payments Payments For Financing Of Insurance Payments Payments For Financing Of Insurance Payments Exit fee Debt Extinguishment, Exit Fee, Amount Debt Extinguishment, Exit Fee, Amount Vendor A Vendor A [Member] Represents the information pertaining to Vendor A. Aggregate principal amount outstanding Long-term debt, gross Total debt Long-Term Debt, Gross Noncompete agreements Noncompete Agreements [Member] Debt Debt, Policy [Policy Text Block] Compensation Amount Outstanding Recovery Compensation Amount Individual: Individual [Axis] Diluted (in shares) Weighted average common shares outstanding, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Warrant Warrant [Member] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Entity Emerging Growth Company Entity Emerging Growth Company Underlying Security Market Price Change Underlying Security Market Price Change, Percent Advances from asset-based revolving facility Proceeds from Lines of Credit Interest rate Accounts Payable, Interest-Bearing, Interest Rate Robert Carter [Member] Robert Carter Less: amount representing interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Other assets Increase (Decrease) in Other Noncurrent Assets Proceeds from secured lines of credit Proceeds from Secured Lines of Credit Revenue from Contract with Customer [Abstract] Conversion Option Derivative Liability Derivative Instrument [Member] Derivative Instrument Tax benefit from stock options exercised Share-Based Payment Arrangement, Exercise of Option, Tax Benefit Computers and software Computer And Software [Member] Represents the information about computers and software. Treasury Stock Treasury Stock, Common [Member] Intangible Asset, Goodwill and Other [Abstract] Common stock issued for warrants exercised Proceeds from Warrant Exercises Organization, Consolidation and Presentation of Financial Statements [Abstract] Total future lease payment Lessee, Operating Lease, Liability, to be Paid Restricted Stock Units and Restricted Stock Awards Restricted Stock Units And Restricted Stock Awards [Member] Restricted Stock Units And Restricted Stock Awards Threshold trading days (in days) Class Of Warrant Or Right, Redemption Of Warrants Or Rights, Threshold Trading Days Class Of Warrant Or Right, Redemption Of Warrants Or Rights, Threshold Trading Days Balance at the beginning (in dollars per share) Balance at the ending (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value All Executive Categories All Executive Categories [Member] IV drug inventory IV Drug Inventory, Segment [Member] IV Drug Inventory, Segment Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Unit price Measurement Input, Unit Price [Member] Measurement Input, Unit Price Summary of Basic and Diluted Net Loss Per Share to Common Stockholders Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Debt Disclosure [Abstract] Segment Information Segment Reporting [Text Block] Minimum Minimum [Member] Warrants price per share (in dollars per share) Class Of Warrant Or Right, Redemption Price Of Warrants Or Rights Class Of Warrant Or Right, Redemption Price Of Warrants Or Rights Liabilities Liabilities [Abstract] Summary of Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Variable Interest Entities Variable Interest Entity Disclosure [Text Block] Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Summary of Estimated Aggregate Amortization Expense Intangible Asset, Finite-Lived, Amortization Expense [Table Text Block] Weighted-average number of shares outstanding: Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Balance at the end (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted-Average Remaining Contractual Term Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Dividends, common stock Dividends, Common Stock Common stock, shares authorized (in shares) Common Stock, Shares Authorized Significant Risks and Uncertainties Including Business and Credit Concentrations Concentration Risk Disclosure [Text Block] Number of shares issued in transaction (in shares) Sale of Stock, Number of Shares Issued in Transaction Exercise Price Award Exercise Price Segment Reporting Segment Reporting [Line Items] Document Quarterly Report Document Quarterly Report Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Interest payable Interest Payable Principal payments on long-term debt Repayments of long-term debt Repayments of Long-Term Debt Preferred stock, liquidation preference per share (in dollars per share) Preferred Stock, Liquidation Preference Per Share Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Other receivables Increase (Decrease) in Other Receivables Equity Component [Domain] Equity Component [Domain] Measurement Input Type [Domain] Measurement Input Type [Domain] Adoption Date Trading Arrangement Adoption Date Counterparty Name [Domain] Counterparty Name [Domain] Total other non-operating expense (income) Nonoperating Income (Expense) Payor A Payor A [Member] Represents the information pertaining to Payor A. Title Trading Arrangement, Individual Title Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Accounting Policies [Abstract] Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Present value of future lease payment (lease liabilities) Operating Lease, Liability Exchange agreement warrants acquired in agreement (in shares) Common Stock, Convertible, Shares Issuable Common Stock, Convertible, Shares Issuable Balance at the beginning (in shares) Balance at the end (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Present value of future lease payment (lease liabilities) Finance Lease, Liability Total segment operating income Other Operating Income Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Selling, general and administrative expense Selling, General and Administrative Expense Repayment of debt Repayments of Debt Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] RSUs Restricted Stock Units (RSUs) [Member] Summary of Computation of Diluted Net Loss Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] All Adjustments to Compensation All Adjustments to Compensation [Member] Proceeds from private placement, net of offering costs Proceeds from Issuance of Private Placement Net cash and cash equivalents provided by (used in) operating activities Net cash provided by (used in) operating Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Accounts Receivable Accounts Receivable [Member] Income Statement [Abstract] Stockholders’ deficit: Equity, Attributable to Parent [Abstract] Share issuances through employee stock purchase plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Document Transition Report Document Transition Report Operating expenses Operating Expenses [Abstract] Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Summary of Intangible Assets, Net Intangible Asset, Finite-Lived [Table Text Block] City Area Code City Area Code Issuance of preferred stock upon exchange of debt for equity Stock Issued During Period, Value, Conversion of Units Document Information [Table] Document Information [Table] Convertible note Convertible Debt Securities [Member] Volatility Measurement Input, Price Volatility [Member] Debt instrument, estimated fair value Debt Instrument, Fair Value Disclosure Name Forgone Recovery, Individual Name Supplier [Domain] Supplier [Domain] Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Recourse Status [Domain] Recourse Status [Domain] Series A preferred shares, shares issued (in shares) Preferred Stock, Shares Issued Summary of Weighted Average Discount Rates Assets and Liabilities, Lessee [Table Text Block] Assets and Liabilities, Lessee Net loss attributable to participating securities, diluted Participating Securities, Distributed and Undistributed Earnings (Loss), Diluted Share issuances through employee stock purchase plan Stock Issued During Period, Value, Employee Stock Purchase Plan Issuance of common stock (in shares) Stock Issued During Period, Shares, New Issues Payor contracts Customer Contracts [Member] Compensation costs recognized Share-Based Payment Arrangement, Expense Issuance of common stock upon exercise of options (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Reporting Unit [Axis] Reporting Unit [Axis] Weighted-average grant date fair value (in dollars per share) Granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Payables and Accruals [Abstract] Forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Summary of Assumptions used in the Valuation of Derivative Liabilities Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Transactions costs related to issuance of long-term debt Payments of Debt Issuance Costs Entity Current Reporting Status Entity Current Reporting Status Net cash and cash equivalents provided by (used in) financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Total Shareholder Return Amount Total Shareholder Return Amount Pre-Funded Warrants Pre-Funded Warrants [Member] Pre-Funded Warrants Inventory [Domain] Inventory [Domain] Senior Secured Term Loan Senior Secured Term Loan [Member] Senior Secured Term Loan Adjustments to reconcile net loss to cash and cash equivalents used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] 2029 Long-Term Debt, Maturity, Year Three Cash flows from financing activities: Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Property and equipment, net Total property and equipment, net Property and equipment, net Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization Warrant Liability Warrant Liability [Member] Warrant Liability Threshold number of business days before sending notice of redemption to warrant holders (in days) Class Of Warrant Or Right, Threshold Number of Business Days Before Sending Notice of Redemption to Warrant Holders Class Of Warrant Or Right, Threshold Number of Business Days Before Sending Notice of Redemption to Warrant Holders Redemption period three Debt Instrument, Redemption, Period Three [Member] Asset-based revolving credit facility Line of Credit, Current Unused line fee percentage Line of Credit Facility, Unused Capacity, Commitment Fee Percentage Financial Instruments [Domain] Financial Instruments [Domain] Inventories Inventory Disclosure [Text Block] Intangible Asset, Finite-Lived, Class [Axis] Intangible Asset, Finite-Lived, Class [Axis] Issuance of common stock upon exercise of options Stock Issued During Period, Value, Stock Options Exercised Goodwill and Intangible Assets Intangible Asset and Goodwill [Text Block] Underlying Securities Award Underlying Securities Amount Revenue Revenue from Contract with Customer [Text Block] Issuance of common stock Stock Issued During Period, Value, New Issues Network medical expense Network Medical Expenses [Member] Network Medical Expenses Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Forfeited (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Preferred Stock Preferred Stock [Member] Inventories Increase (Decrease) in Inventories Operating Operating Lease, Weighted Average Discount Rate, Percent Summary of the Activity for the RSUs and RSAs Nonvested Restricted Stock Shares Activity [Table Text Block] Segment Reporting [Table] Segment Reporting [Table] FFS revenue Fee For Service [Member] Represents the information about FFS revenue. Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Summary of Lease Cost Lease, Cost [Table Text Block] Commitments and Contingencies Disclosure [Abstract] All Trading Arrangements All Trading Arrangements [Member] Beginning balance Ending balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Other Performance Measure, Amount Other Performance Measure, Amount Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Current Fiscal Year End Date Current Fiscal Year End Date Intravenous (IV) drug costs Intravenous (IV) Drug Costs, Segment [Member] Intravenous (IV) Drug Costs, Segment Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Entity File Number Entity File Number Summary of Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Weighted average exercise price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Measure: Measure [Axis] Summary of Consolidated Financial Statements of VIEs Schedule of Variable Interest Entities [Table Text Block] Right-of-use assets in connection with operating lease modifications Right-Of-Use Assets In Connection With Operating Lease Modifications Right-Of-Use Assets In Connection With Operating Lease Modifications Treasury stock (in shares) Treasury Stock, Common, Shares Equity Components [Axis] Equity Components [Axis] Related party Related Party [Member] Income taxes Income Tax Paid, after Refund Received Due After Five Years Debt Securities, Available-For-Sale, Amortized Cost, Maturity, Allocated And Single Maturity Date, After Year 5 Debt Securities, Available-For-Sale, Amortized Cost, Maturity, Allocated And Single Maturity Date, After Year 5 Common Class A Common Class A [Member] Entity Interactive Data Current Entity Interactive Data Current Lease liabilities, current Finance Lease, Liability, Current Due After One Year through Five Years Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five Issuance of preferred stock upon exchange of debt for equity (in shares) Stock Issued During Period, Shares, Conversion of Units Entity Small Business Entity Small Business Unamortized debt discount Less: Unamortized debt discount Debt Instrument, Unamortized Discount Property and Equipment, Net Property, Plant, and Equipment [Line Items] Number of monthly installments Number Of Instalments Payable Number Of Instalments Payable MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Other assets Other Assets, Noncurrent 2029 Finance Lease, Liability, to be Paid, Year Three Document Type Document Type Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Loss on debt extinguishment Loss on debt extinguishment Gain (Loss) on Extinguishment of Debt Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Vested options exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Statement of Stockholders' Equity [Abstract] Proceeds from issuance of long-term debt Proceeds from Issuance of Long-Term Debt Local Phone Number Local Phone Number Accrued interest Debt Instrument, Accrued Interest Debt Instrument, Accrued Interest Accrued sub-capitation Accrued Sub-Capitation, Current Accrued Sub-Capitation, Current Exit fee and make-whole paid on debt extinguishment Payment for Debt Extinguishment or Debt Prepayment Cost B. Riley Securities B. Riley Securities [Member] B. Riley Securities Loss before provision for income taxes Consolidated loss before provision for income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Nonrecourse Nonrecourse [Member] Warrants term (in years) Warrants and Rights Outstanding, Term Commitments and contingencies (Note 15) Commitments and Contingencies Debt Instrument, Redemption, Period [Domain] Debt Instrument, Redemption, Period [Domain] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Property and equipment, gross Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] 2030 Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Four Executive Category: Executive Category [Axis] Receivable Type [Axis] Receivable Type [Axis] Counterparty Name [Axis] Counterparty Name [Axis] Liabilities and stockholders’ deficit Liabilities and Equity [Abstract] Inventories Total Inventories Inventory, Net Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Number of warrants outstanding (in shares) Class of Warrant or Right, Outstanding Variable Interest Entity [Table] Variable Interest Entity [Table] Supplemental disclosure of cash flow information: Supplemental cash flow information Supplemental Cash Flow Information [Abstract] PEO Name PEO Name Financing cash payments for finance leases Repayments for Finance Lease Repayments for Finance Lease Leasehold improvements Leasehold Improvements [Member] Financial liabilities: Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract] Long-Lived Asset, Class [Axis] Long-Lived Asset, Class [Axis] Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Entity Tax Identification Number Entity Tax Identification Number Exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Class of warrants, common stock, exercise price percentage Class Of Warrant Or Right, Ownership Threshold Percentage Class Of Warrant Or Right, Ownership Threshold Percentage Accounts payable Increase (Decrease) in Accounts Payable Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Debt Instrument [Axis] Debt Instrument [Axis] Share-based compensation Share-Based Payment Arrangement, Noncash Expense Purchase price of common stock, percent Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent Number of lease modifications Lessee, Operating Lease, Number Of Leases Extended Lessee, Operating Lease, Number Of Leases Extended Conversion of preferred stock to common stock (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Basic (in dollars per share) Net loss income per share attributable to common stockholders, basic (in dollars per share) Earnings Per Share, Basic Daniel Virnich [Member] Daniel Virnich Measurement Input Type [Axis] Measurement Input Type [Axis] Total current assets Assets, Current Insider Trading Arrangements [Line Items] Long-term debt, net of unamortized debt issuance costs Long-Term Debt, Excluding Current Maturities Common Warrants in connection with private placement and exchange agreement Common Warrants With Private Placement [Member] Common Warrants With Private Placement Short-term lease costs Short-Term Lease, Cost Accounts receivable, net Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Gross payables Accounts Payable [Member] Minimum number of oncologists and mid-level professionals within three states Number Of Oncologists And Mid-Level Professionals Within Three States, Minimum Represents the minimum number of oncologists and mid-level professionals within three states. Oral drug accounts receivable (Specialty Pharmacy) Oral Drug Accounts Receivable [Member] Represents the information pertaining to oral drug accounts receivable. Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Cover [Abstract] 2021 Plan Two Thousand And Twenty One Plan [Member] Two Thousand And Twenty One Plan Concentration risk percentage Concentration Risk, Percentage Equity Awards Adjustments Equity Awards Adjustments [Member] Conversion option derivative liabilities Derivative Liability, Noncurrent Minimum net quarterly revenues Debt Instrument, Covenant, Minimum Net Quarterly Revenues Debt Instrument, Covenant, Minimum Net Quarterly Revenues Liability classified warrants Liability Classified Warrants, Noncurrent Liability Classified Warrants, Noncurrent Plan Name [Axis] Plan Name [Axis] Summary of Accounts Receivable Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] Fair value measurements inputs Derivative Liability, Measurement Input Inventory Disclosure [Abstract] Purchases of property and equipment included in accounts payable Purchases Of Property, Plant and Equipment Included in Accounts Payable Purchases Of Property, Plant and Equipment Included in Accounts Payable Intangible Asset, Finite-Lived, after Accumulated Amortization [Abstract] Intangible Asset, Finite-Lived, after Accumulated Amortization [Abstract] Other non-current liabilities Increase (Decrease) in Other Noncurrent Liabilities Other, net Other, net Other Nonoperating Income (Expense) Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Series A preferred shares, authorized (in shares) Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Derivatives, Fair Value [Line Items] Derivatives, Fair Value [Line Items] Class of Stock [Domain] Class of Stock [Domain] Statement of Cash Flows [Abstract] Cost of equity Measurement Input, Cost Of Equity [Member] Measurement Input, Cost Of Equity Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Investments in Marketable Securities Investment, Policy [Policy Text Block] Financing arrangement Accounts Payable Income Taxes Income Tax Disclosure [Text Block] Accounts payable Accounts payable Accounts Payable, Current Convertible note warrant Convertible Note Warrant [Member] Convertible Note Warrant Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Entity Filer Category Entity Filer Category Other assets Other Assets, Segment [Member] Other Assets, Segment Effective yield (as a percent) Debt Instrument, Interest Rate During Period Finance Leases Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] Cash paid for: Cash Paid For [Abstract] Cash Paid For Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Stock, Class of Stock [Table] Stock, Class of Stock [Table] Current assets: Assets, Current [Abstract] Entity Address, Address Line One Entity Address, Address Line One Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Income tax benefit Income tax expense (benefit) Income Tax Expense (Benefit) Transactions costs related to issuance of asset-based revolving facility Payments of Loan Costs Incremental cash Debt Extinguishment, Incremental Cash Payment, Amount Debt Extinguishment, Incremental Cash Payment, Amount Comprehensive Loss Comprehensive Income, Policy [Policy Text Block] Risks and Uncertainties [Abstract] Principles of Consolidation Consolidation, Policy [Policy Text Block] Revolving Loan Agreement Revolving Loan Agreement [Member] Revolving Loan Agreement Variable interest entity Variable Interest Entity, Primary Beneficiary [Member] Statement [Table] Statement [Table] Items not allocated to segments Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment [Member] Equal monthly-basis vesting through fourth anniversary of grant date Share-Based Payment Arrangement, Tranche Two [Member] Common stock issued for options exercised Proceeds from Stock Options Exercised Exchange agreement, principal amount of debt exchanged for securities Debt Conversion, Converted Instrument, Amount Accrued interest receivable on cash equivalents and marketable securities Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss, Current